623 results Stibbe Brussels reinforces Public Law and EU/Competition Law practices with two Counsel appointments Stibbe Brussels has promoted Sophie Adriaenssen to Counsel in its Public Law practice group and has welcomed Quentin Declève as Counsel in its EU/Competition Law practice. The appointments are effective as per 1 January 2023. Stibbe Brussel versterkt praktijken Publiekrecht en EU/Competition met twee counselbenoemingen Stibbe Brussel heeft Sophie Adriaenssen benoemd tot Counsel in zijn praktijkgroep Publiekrecht. Het kantoor heeft daarnaast Quentin Declève verwelkomd als Counsel in zijn praktijkgroep EU/Competition. De nieuwe benoemingen gelden vanaf 1 januari 2023. Stibbe Bruxelles renforce ses pratiques en droit public et en droit de l'UE/de la concurrence par la nomination de deux Counsel Le bureau bruxellois de Stibbe a nommé Sophie Adriaenssen en tant que Counsel au sein de sa pratique de droit public. Le cabinet a également accueilli Quentin Declève en tant que Counsel au sein de sa pratique de droit de l'UE/de la concurrence. Belgian watchdog tackles bid rigging In recent cases in the fire protection and private security sectors, the Belgian Competition Authority has made the prosecution of bid-rigging one of its top priorities, imposing hefty fines on infringers for their participation in cartel schemes. Eigen verklaringen in documentatie: artikel 19 WED en het nemo tenetur-beginsel De ruime bevoegdheid van artikel 19 WED om documenten te vorderen roept de vraag op hoe dit zich verhoudt tot het nemo tenetur-beginsel wanneer het gaat om wilsafhankelijke documenten die eigen verklaringen van de verdachte bevatten. Steekproefsgewijze sanity checks: geen werk voor opsporingsambtenaren Onlangs publiceerde de Rechtbank Overijssel een beslissing die weer relevante inzichten biedt ten aanzien van de omgang met geheimhouderinformatie. Court of Appeal overturns first instance judgment and establishes that several prestressing steel producers are liable for the potential loss alleged by Deutsche Bahn The Court of Appeal of 's-Hertogenbosch ruled that several producers of prestressing steel are jointly and severally liable for potential loss that Deutsche Bahn may have suffered as a result of an infringement of competition law rules. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices. Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten. You win some, you lose some: Google AdSense decision annulled The General Court has annulled the EUR 1.49 billion fine imposed on Google. The Commission had failed to properly assess the allegedly abusive contractual clauses related to online advertising, including whether they actually had a lock-in effect. ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom. Het verschoningsrecht is niet zomaar prijsgegeven Het verschoningsrecht blijft de gemoederen bezighouden. Verschoningsgerechtigde informatie omvat alle informatie die aan een advocaat is toevertrouwd door zijn cliënt in het kader van hun professionele relatie. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies. Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission. Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update! Pagination Previous page Page 29 Current page 30 Page 31 Page 32 Next page
Stibbe Brussels reinforces Public Law and EU/Competition Law practices with two Counsel appointments Stibbe Brussels has promoted Sophie Adriaenssen to Counsel in its Public Law practice group and has welcomed Quentin Declève as Counsel in its EU/Competition Law practice. The appointments are effective as per 1 January 2023.
Stibbe Brussel versterkt praktijken Publiekrecht en EU/Competition met twee counselbenoemingen Stibbe Brussel heeft Sophie Adriaenssen benoemd tot Counsel in zijn praktijkgroep Publiekrecht. Het kantoor heeft daarnaast Quentin Declève verwelkomd als Counsel in zijn praktijkgroep EU/Competition. De nieuwe benoemingen gelden vanaf 1 januari 2023.
Stibbe Bruxelles renforce ses pratiques en droit public et en droit de l'UE/de la concurrence par la nomination de deux Counsel Le bureau bruxellois de Stibbe a nommé Sophie Adriaenssen en tant que Counsel au sein de sa pratique de droit public. Le cabinet a également accueilli Quentin Declève en tant que Counsel au sein de sa pratique de droit de l'UE/de la concurrence.
Belgian watchdog tackles bid rigging In recent cases in the fire protection and private security sectors, the Belgian Competition Authority has made the prosecution of bid-rigging one of its top priorities, imposing hefty fines on infringers for their participation in cartel schemes.
Eigen verklaringen in documentatie: artikel 19 WED en het nemo tenetur-beginsel De ruime bevoegdheid van artikel 19 WED om documenten te vorderen roept de vraag op hoe dit zich verhoudt tot het nemo tenetur-beginsel wanneer het gaat om wilsafhankelijke documenten die eigen verklaringen van de verdachte bevatten.
Steekproefsgewijze sanity checks: geen werk voor opsporingsambtenaren Onlangs publiceerde de Rechtbank Overijssel een beslissing die weer relevante inzichten biedt ten aanzien van de omgang met geheimhouderinformatie.
Court of Appeal overturns first instance judgment and establishes that several prestressing steel producers are liable for the potential loss alleged by Deutsche Bahn The Court of Appeal of 's-Hertogenbosch ruled that several producers of prestressing steel are jointly and severally liable for potential loss that Deutsche Bahn may have suffered as a result of an infringement of competition law rules.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices.
Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten.
You win some, you lose some: Google AdSense decision annulled The General Court has annulled the EUR 1.49 billion fine imposed on Google. The Commission had failed to properly assess the allegedly abusive contractual clauses related to online advertising, including whether they actually had a lock-in effect.
ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom.
Het verschoningsrecht is niet zomaar prijsgegeven Het verschoningsrecht blijft de gemoederen bezighouden. Verschoningsgerechtigde informatie omvat alle informatie die aan een advocaat is toevertrouwd door zijn cliënt in het kader van hun professionele relatie.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies.
Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission.
Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update!